Duration of the first remission and survival rate of children with acute lymphoblastic leukemia after use of thymus preparations in the remission period
Kisliak, N.S.; Chernov, V.M.; Kondratchik, K.L.; Pronina, L.K.; Stolov, A.M.
Gematologiia i Transfuziologiia 39(5): 43-44
1994
ISSN/ISBN: 0234-5730 PMID: 7896035 Document Number: 428228
Document emailed within 1 workday
Related Documents
Gavrilova, I.E.; Kuznetsov, I.P.; Denisov, L.A.; Maiakova, S.A.; Orlova, T.G.; Kadagidze, Z.G.; Makhonova, L.A. 1991: Use of alpha interferon preparations in acute lymphoblastic leukemia in children during remission Pediatriia 11: 75-78Lauria, F.; Raspadori, D.; Rondelli, D.; Ventura, M.A.; Foà, R. 1994: In vitro susceptibility of acute leukemia cells to the cytotoxic activity of allogeneic and autologous lymphokine activated killer (LAK) effectors: correlation with the rate and duration of complete remission and with survival Leukemia 8(5): 724-728
Mokrzycka, M.łg.; Pawlik, A.; Kałdońska, M.; Millo, B. 2006: Assessment of liver function in children with acute lymphoblastic leukemia in remission Annales Academiae Medicae Stetinensis 52(3): 61
Zajaczkowski, J.; Pituch, A.; Kolanowska, H.; Michalik, R. 1975: Some immunological aspects of the long-term remission in acute lymphoblastic leukemia in children Folia Haematologica 102(4): 403-409
Moussalem, M.; Esperou Bourdeau, H.; Devergie, A.; Baruchel, A.; Ribaud, P.; Socie, G.; Parquet, N.; Traineau, R.; Hirsch, I.; Schaison, G. 1995: Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease Bone Marrow Transplantation 15(6): 943-947
2007: E2902: A Phase III randomized study of farnesyl transferase inhibitor R115777 in acute myeloid leukemia patients in second or subsequent remission or in remission after primary induction failure or patients over age 60 in first remission Clinical Advances in Hematology and Oncology: H&o 5(1): 13-14
Kaftański, R. 1979: Immunological characteristics of lymphocytes during intensive treatment maintaining remission of acute lymphoblastic leukemia in children and following withdrawal from chemotherapy Acta Haematologica Polonica 10(2): 99-106
Lin, W.; Xie, J.; Zhang, J.; Cheng, H.; Cui, H.; Zhang, Y.; Wu, Y.; Yu, J.; Qi, P.; Fan, J.; Gao, H.; Wang, F.; Zhang, R.; Zheng, H. 2019: Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia during remission induction chemotherapy: a single-center retrospective study Minerva Pediatrica 2019
Aur, R.J.; Simone, J.V.; Verzosa, M.S.; Hustu, H.O.; Barker, L.F.; Pinkel, D.P. 1975: Comparison of four schedules of chemotherapy during remission of acute lymphoblastic leukemia in childhood Sangre 20(3): 237-244
Laila, R.; Islam, A.; Bhuiyan, M.M. 2016: Incidence of Hyperglycemia during Induction of Remission Phase of Pediatric Acute Lymphoblastic Leukemia Mymensingh Medical Journal: Mmj 25(4): 730-735
Larson, R.A.; Lukin, C.L.; Daly, K.M.; Mick, R.; Gore, S.; Le Beau, M.M. 1991: Circulating immune complexes correlate with remission duration in acute myeloid leukemia Leukemia 5(2): 131-137
Andreasson, P.; Johansson, B.; Arheden, K.; Tedgård, U.; Ljung, R.; Heim, S.; Mitelmann, F. 1996: Emergence of novel transient clonal chromosomal bone marrow changes in remission of acute lymphoblastic leukemia Leukemia 10(2): 378-383
Vey, N.; Blaise, D.; Stoppa, A.M.; Bouabdallah, R.; Lafage, M.; Sainty, D.; Cowen, D.; Viens, P.; Lepeu, G.; Blanc, A.P. 1994: Bone marrow transplantation in 63 adult patients with acute lymphoblastic leukemia in first complete remission Bone Marrow Transplantation 14(3): 383-388
Devaraj, P.E.; Foroni, L.; Janossy, G.; Hoffbrand, A.V.; Secker-Walker, L.M. 1995: Expression of the E2A-PBX1 fusion transcripts in t(1;19)(q23;p13) and der(19)t(1;19) at diagnosis and in remission of acute lymphoblastic leukemia with different B lineage immunophenotypes Leukemia 9(5): 821-825
Hafiz, M.G.; Mannan, M.A. 2008: Nutritional status at initial presentation in childhood acute lymphoblastic leukemia and its effect on induction of remission Mymensingh Medical Journal: Mmj 17(2 Suppl): S46-S51
Piccaluga, P.Paolo.; Martinelli, G.; Malagola, M.; Rondoni, M.; Bianchini, M.; Visani, G.; Baccarani, M. 2003: Complete remission in acute myeloid leukemia with granulocyte-colony stimulating factor without chemotherapy. Report of cytogenetic remission of a t(9;11)(p22q23) positive AML patient and review of literature Haematologica 88(8): Ecr28
Ladetto, M.; Corradini, P.; Astolfi, M.; Campana, S.; Tarella, C.; Pileri, A. 1996: Long-term molecular remission after conventional chemotherapy in a patient with Philadelphia-negative acute lymphoblastic leukemia Haematologica 81(2): 159-161
Torres, A.; Martínez, F.; Gómez, P.; Fornés, G.; Rojas, R.; Herrera, C.; Gómez, J.L.; Manzanares, R.; García, J.M.; Andres, P. 1989: Allogeneic bone marrow transplantation versus chemotherapy in the treatment of childhood acute lymphoblastic leukemia in second complete remission Bone Marrow Transplantation 4(6): 609-612
Kawashima, K.; Nagura, E.; Yamada, K.; Hamajima, N. 1986: Primary relapse in patients with acute leukemia after an initial 5-year period of complete remission Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 49(7): 1354-1359
Pituch, A. 1977: Peripheral blood neutrophils in children in remission of acute lymphoblastic leukaemia. Cytochemical investigations Acta Medica Polona 18(1): 69-83